Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AB BioTechnologies Details Expansion | Contract Pharma

What are you searching for?

Sign in
Videos

AB BioTechnologies Details Expansion

Dr. Jeff Schwegman details the features of AB's expansion; a new, 23,000 sq. ft. facility

By: Betsy Louda

, Contract Pharma



Dr. Jeff Schwegman, founder and chief executive officer at AB BioTechnologies, spoke with Contract Pharma at CPhI North America 2018 to announce their ongoing expansion in the contract manufacturing of clinical trial supplies.

The expansion includes a 23,000 sq. ft. facility, which features labs, manufacturing areas, controlled temperature storage, and packaging and labeling capabilities. A state-of-the-art, totally enclosed, robotically operated filling line will also be featured in the new facility. AB Bio’s goal is to have capability to offer clients services from early stage development, all the way to small-scale commerical batch manufacturing.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics